FQI1, >=98% (HPLC)

FQI1, >=98% (HPLC)

Biochem/physiol Actions

FQI1 inhibits the DNA-binding activity of LSF, a ubiquitous transcription factor that is up regulated in many hepatocellular carcinomas (HCC). FQI1 inhibits LSF-dependent luciferase reporter expression, blocks proliferation in cancer cell lines, and induces apoptosis in liver cancer cells but is not toxic to primary hepatocytes. FQI1 also inhibits tumor growth in a mouse HCC xenograft model.

Packaging

5, 25 mg in glass bottle

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Colour Quality Level InChI key InChI Manufacturer Solubility Form Assay Price Quantity
3574068 FQI1, >=98% (HPLC) white to beige 100 YKSYGLXHLSPWLB-UHFFFAOYSA-N 1S/C18H17NO4/c1-2-21-15-6-4-3-5-11(15)12-8-18(20)19-14-9-17-16(7-13(12)14)22-10-23-17/h3-7,9,12H,2,8,10H2,1H3,(H,19,20) SIGMA-ALDRICH DMSO: 10 mg/mL (clear solution) powder ≥98% (HPLC)
£412.29 (exc VAT) per 25MG
-
+
3574069 FQI1, >=98% (HPLC) white to beige 100 YKSYGLXHLSPWLB-UHFFFAOYSA-N 1S/C18H17NO4/c1-2-21-15-6-4-3-5-11(15)12-8-18(20)19-14-9-17-16(7-13(12)14)22-10-23-17/h3-7,9,12H,2,8,10H2,1H3,(H,19,20) SIGMA-ALDRICH DMSO: 10 mg/mL (clear solution) powder ≥98% (HPLC)
£146.25 (exc VAT) per 5MG
-
+